Joke Bilcke, Ph.D.
Affiliations: | 2011 | Universiteit Antwerpen (Belgium) |
Area:
General, Biostatistics Biology, Public HealthGoogle:
"Joke Bilcke"Cross-listing: PHTree
Parents
Sign in to add mentor| Pierrre V. Damme | grad student | 2011 | Universiteit Antwerpen (Belgium) | |
| (Exploring uncertainty in the economic evaluation of vaccination programs.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Koltai M, Moyes J, Nyawanda B, et al. (2023) Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa. Bmc Medicine. 21: 120 |
| Phillips MT, Antillon M, Bilcke J, et al. (2023) Cost-effectiveness analysis of typhoid conjugate vaccines in an outbreak setting: a modeling study. Bmc Infectious Diseases. 23: 143 |
| Li X, Hodgson D, Flaig J, et al. (2022) Cost-effectiveness of respiratory syncytial virus preventive interventions in children: a model comparison study. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research |
| Bilcke J, Beutels P. (2022) Authors' Reply to Comment on "Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison Between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine". Pharmacoeconomics. 40: 1013-1014 |
| Li X, Bilcke J, Vázquez Fernández L, et al. (2022) Cost-effectiveness of Respiratory Syncytial Virus Disease Prevention Strategies: Maternal Vaccine Versus Seasonal or Year-Round Monoclonal Antibody Program in Norwegian Children. The Journal of Infectious Diseases |
| Birger R, Antillón M, Bilcke J, et al. (2022) Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modelling study. The Lancet. Infectious Diseases |
| Pieters Z, Ogunjimi B, Beutels P, et al. (2022) Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine. Pharmacoeconomics |
| Pitzer VE, Pollard AJ, Bilcke J. (2021) Strategies for typhoid conjugate vaccines in endemic nations - Authors' reply. The Lancet. Infectious Diseases. 21: 321-322 |
| Pieters Z, Strong M, Pitzer VE, et al. (2020) A Computationally Efficient Method for Probabilistic Parameter Threshold Analysis for Health Economic Evaluations. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 272989X20937253 |
| Moreno-Gutierrez D, Rosas-Aguirre A, Llanos-Cuentas A, et al. (2020) Economic costs analysis of uncomplicated malaria case management in the Peruvian Amazon. Malaria Journal. 19: 161 |